Opportunity in Crisis

Opportunity in Crisis

Membership required to view content.
 that they will seek approval for the newly developed COVID-19 vaccine is a shot in the arm for unsure global markets.  Today’s market activity reflects participants ambivalence, weighing the game changing vaccine with economic fallout from impending lockdown measures.  Pfizer’s collaboration has yielded a vaccine that is apparently over 90% effective, and safe. 

Pfizer says they will apply for Emergency Use Authorization (EUA) with the FDA imminently, after the required safety milestone is achieved.  Pfizer, with a $50 billion+ market cap has an historical working relationship with the FDA, having gained approval for some of the most widely used drugs, like Lipitor, Viagra, or Zoloft.  The vaccine trial began in…

Membership is required to view the rest of this post.
Click here to learn more and sign up for a free 7-day trial!

Blog

12.20.2024

45z guidance fails to appear; government scrambles to pass spending bill

45z guidance fails to appear; government scrambles to pass spending bill

The US government spending bill failed twice in as many days. If a deal is not reached by midnight on Friday December 20, some federal services will...

12.20.2024

US animal fats and oils end week softer across the board ahead of holiday slowdown

US animal fats and oils end week softer across the board ahead of holiday slowdown

Prices for US animal fats and oils ended the week on a lower note on Friday December 20, with most markets trending downward ahead of the upcoming holiday week,...

12.20.2024

December cattle on feed down on month, year

December cattle on feed down on month, year

Most US animal protein prices were rangebound for the week, though in wider ranges due to the impending Christmas and New Year's holiday closures.

The only significant price...

Latest Tweets